Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$8,167,479
+$5,342,720 QoQ
Shares Held
32,457
+149.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#1,027
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SNS Financial Group, LLC holds $152,677,395 across 10 Drug Manufacturers - General names. ABBV ranks #4 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
46,863 | $56,208,892 | |
| 2 | JNJ |
Johnson & Johnson
|
172,754 | $43,874,333 | |
| 3 | NVO |
Novo Nordisk A S
|
669,858 | $32,112,992 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
32,457 | $8,167,479 | |
| 5 | PFE |
Pfizer Inc
|
167,096 | $4,023,671 | |
| 6 | MRK |
Merck & Co., Inc.
|
27,952 | $3,591,832 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
36,127 | $2,081,637 | |
| 8 | AMGN |
Amgen Inc
|
2,842 | $1,029,145 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,167,479 | 32,457 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $2,824,759 | 12,988 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $2,971,511 | 13,005 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $1,675,886 | 7,238 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,339,990 | 7,219 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $1,514,201 | 7,227 | Shares | Defined | 2025-05-05 | |
| 2024-12-31 | $1,290,456 | 7,262 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $1,457,006 | 7,378 | Shares | Defined | 2024-11-01 | |
| 2024-06-30 | $1,259,985 | 7,346 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $1,330,240 | 7,305 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $1,122,757 | 7,245 | Shares | Defined | 2024-01-22 | |
| 2023-09-30 | $1,119,887 | 7,513 | Shares | Defined | 2023-10-19 | |
| 2023-06-30 | $1,002,121 | 7,438 | Shares | Defined | 2023-07-17 | |
| 2023-03-31 | $1,204,677 | 7,559 | Shares | Defined | 2023-04-28 | |
| 2022-12-31 | $1,661,511 | 10,281 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $1,344,649 | 10,019 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $1,527,923 | 9,976 | Shares | Defined | 2022-07-22 | |
| 2022-03-31 | $1,632,123 | 10,068 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $1,393,266 | 10,290 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,122,603 | 10,407 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,172,019 | 10,405 | Shares | Defined | 2021-08-02 | |
| 2021-03-31 | $1,112,176 | 10,277 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $942,597 | 8,797 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $794,790 | 9,074 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $890,786 | 9,073 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $669,710 | 8,790 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||